Variant report
Variant | esv3361600 |
---|---|
Chromosome Location | chr5:124626989-124628140 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs552571367 | chr5:124626989-124626990 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs566034770 | chr5:124626999-124627000 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs559642811 | chr5:124627004-124627005 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs533325616 | chr5:124627008-124627009 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs566088674 | chr5:124627017-124627018 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs535067941 | chr5:124627172-124627173 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs533124604 | chr5:124627184-124627185 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs113527795 | chr5:124627200-124627201 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs34720319 | chr5:124627209-124627210 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs72532872 | chr5:124627213-124627214 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs548848710 | chr5:124627217-124627218 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs189657771 | chr5:124627294-124627295 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs10519810 | chr5:124627321-124627322 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs11750563 | chr5:124627358-124627359 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
15 | rs567445259 | chr5:124627446-124627447 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs534833854 | chr5:124627487-124627488 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs536281470 | chr5:124627509-124627510 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs78930989 | chr5:124627510-124627511 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs182633846 | chr5:124627511-124627512 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs143086809 | chr5:124627539-124627540 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs77267032 | chr5:124627551-124627552 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs575234449 | chr5:124627554-124627555 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs187091589 | chr5:124627632-124627633 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs535951808 | chr5:124627645-124627646 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs79151937 | chr5:124627753-124627754 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs556817328 | chr5:124627754-124627755 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs62373330 | chr5:124627815-124627816 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
28 | rs145091534 | chr5:124627823-124627824 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs559578403 | chr5:124627854-124627855 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs148360324 | chr5:124627878-124627879 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs545730648 | chr5:124627899-124627900 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs4836168 | chr5:124627978-124627979 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs546246197 | chr5:124628010-124628011 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs62373331 | chr5:124628055-124628056 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
35 | rs34061745 | chr5:124628096-124628097 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Metanephric adenoma | 20802469 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Cancer | 16751803 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Melanoma | 18172304 | CNVD |
Glioma | 20126413 | CNVD |
Cancer | 22429812 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Breast cancer | 21858162 | CNVD |
Leukemia | 17361228 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
5q-syndrome | 17576883 | CNVD |
Gastric cancer | 17908304 | CNVD |
Lung cancer | 16740712 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
Lung cancer | 18438408 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Breast cancer | 21785460 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 17133270 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Cancer | 20164920 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Renal cell carcinoma | 19377443 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Breast cancer | 16397240 | CNVD |
Parathyroid adenoma | 22454399 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:124614400-124631400 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
2 | chr5:124622400-124627200 | Weak transcription | HUES64 Cell Line | embryonic stem cell |
3 | chr5:124622400-124628600 | Weak transcription | Fetal Brain Male | brain |
4 | chr5:124624600-124628000 | Enhancers | Liver | Liver |
5 | chr5:124626600-124627200 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
6 | chr5:124627200-124627400 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
7 | chr5:124627200-124627600 | Enhancers | HUES48 Cell Line | embryonic stem cell |
8 | chr5:124627200-124627600 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
9 | chr5:124627200-124627800 | Enhancers | HUES64 Cell Line | embryonic stem cell |
10 | chr5:124627200-124627800 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
11 | chr5:124627400-124627600 | Enhancers | Fetal Brain Female | brain |
12 | chr5:124627400-124628800 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
13 | chr5:124627600-124628600 | Weak transcription | Fetal Brain Female | brain |
14 | chr5:124627600-124629200 | Enhancers | Primary B cells from peripheral blood | blood |
15 | chr5:124627800-124633800 | Weak transcription | HUES64 Cell Line | embryonic stem cell |
16 | chr5:124628000-124629800 | Enhancers | Dnd41 | blood |